X

Vous n'êtes pas connecté

  - PHILSTAR.COM - Lifestyle - 27/Jun 08:52

Sam Milby undergoes stem cell therapy to 'reverse' diabetes

Actor Sam Milby recently underwent a medical process involving stem cell therapy to manage his diabetes.

Articles similaires

Sorry! Image not available at this time

Diabetic woman no longer needs insulin after single stem cell treatment — why it’s not ...

wn.com - 24/Jun 07:25

A Canadian nurse has kicked insulin to the curb after just one dose of an experimental stem cell therapy, with experts calling it a milestone in the...

Sorry! Image not available at this time

Diabetic woman no longer needs insulin after single stem cell treatment — why it’s not ...

wn.com - 24/Jun 07:25

A Canadian nurse has kicked insulin to the curb after just one dose of an experimental stem cell therapy, with experts calling it a milestone in the...

Photo: Suryakumar undergoes sports hernia surgery, shares update

times of india - 26/Jun 05:42

Indian T20I captain Suryakumar Yadav recently underwent surgery in Munich, Germany, for a sports hernia. Yadav, who last represented India in a T20I...

Sorry! Image not available at this time

New dawn for NeuroScientific with stem cell acquisition

smh.com.au - 27/Jun 02:41

NeuroScientific Biopharmaceuticals has ventured into the stem cell therapy market with a $5.1 million purchase of unlisted Perth-based company...

Sorry! Image not available at this time

New dawn for NeuroScientific with stem cell acquisition

smh.com.au - 27/Jun 02:41

NeuroScientific Biopharmaceuticals has ventured into the stem cell therapy market with a $5.1 million purchase of unlisted Perth-based company...

New dawn for NeuroScientific with stem cell acquisition

thewest.com.au - 27/Jun 02:55

NeuroScientific Biopharmaceuticals has ventured into stem cell therapy with a $5.1M purchase of unlisted Perth-based company Isopogen, whose tech...

New dawn for NeuroScientific with stem cell acquisition

thewest.com.au - 27/Jun 02:55

NeuroScientific Biopharmaceuticals has ventured into stem cell therapy with a $5.1M purchase of unlisted Perth-based company Isopogen, whose tech...

Les derniers communiqués

  • Aucun élément